SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-010201
Filing Date
2019-08-30
Accepted
2019-08-30 16:10:49
Documents
19
Period of Report
2019-08-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT edesa_8k.htm 8-K 62828
2 LEASE edsa_ex101.htm EX-10.1 141780
3 EXCLUSIVE LICENSE AGREEMENT edsa_ex102.htm EX-10.2 425083
4 FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT edsa_ex103.htm EX-10.3 58044
5 SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT edsa_ex104.htm EX-10.4 51298
6 EXCLUSIVE LICENSE AGREEMENT edsa_ex105.htm EX-10.5 417104
7 LICENSE AND DEVELOPMENT AGREEMENT edsa_ex106.htm EX-10.6 306559
8 IMAGE edesa_ex102000.jpg GRAPHIC 14960
9 IMAGE edesa_ex102001.jpg GRAPHIC 6125
10 IMAGE edsa_ex102000.jpg GRAPHIC 14960
11 IMAGE edsa_ex102001.jpg GRAPHIC 6125
12 IMAGE edsa_ex993000.jpg GRAPHIC 3333
13 IMAGE edsa_ex994000.jpg GRAPHIC 675
14 IMAGE edsa_ex994001.jpg GRAPHIC 675
15 IMAGE edsa_ex994002.jpg GRAPHIC 675
16 IMAGE edsa_ex994003.jpg GRAPHIC 851
17 IMAGE edsa_sig.jpg GRAPHIC 29024
18 IMAGE edsa_sig2.jpg GRAPHIC 11425
19 IMAGE ex995scheda000.jpg GRAPHIC 38719
  Complete submission text file 0001654954-19-010201.txt   1641168
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 191069670
SIC: 2834 Pharmaceutical Preparations